Citigroup’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,755
| Closed | -$31K | – | 7868 |
|
|
2020
Q4 | $31K | Buy |
2,755
+2,065
| +299% | +$23.5K | ﹤0.01% | 6388 |
|
|
2020
Q3 | $5K | Sell |
690
-4,370
| -86% | -$28.7K | ﹤0.01% | 7076 |
|
|
2020
Q2 | $33K | Sell |
5,060
-3,330
| -40% | -$21.5K | ﹤0.01% | 6267 |
|
|
2020
Q1 | $55K | Buy |
8,390
+1,511
| +22% | +$13.2K | ﹤0.01% | 5905 |
|
|
2019
Q4 | $71K | Buy |
6,879
+1,744
| +34% | +$14.9K | ﹤0.01% | 6048 |
|
|
2019
Q3 | $32K | Sell |
5,135
-3,441
| -40% | -$25.6K | ﹤0.01% | 6429 |
|
|
2019
Q2 | $63K | Buy |
8,576
+3,883
| +83% | +$25.6K | ﹤0.01% | 6275 |
|
|
2019
Q1 | $28K | Buy |
4,693
+95
| +2% | +$1.1K | ﹤0.01% | 6780 |
|
|
2018
Q4 | $53K | Sell |
4,598
-205
| -4% | -$3.5K | ﹤0.01% | 6199 |
|
|
2018
Q3 | $104K | Sell |
4,803
-1,772
| -27% | -$33.5K | ﹤0.01% | 5872 |
|
|
2018
Q2 | $104K | Buy |
6,575
+2,496
| +61% | +$39.2K | ﹤0.01% | 5689 |
|
|
2018
Q1 | $77K | Buy |
4,079
+2,724
| +201% | +$53.7K | ﹤0.01% | 5841 |
|
|
2017
Q4 | $24K | Buy |
1,355
+1,055
| +352% | +$14.6K | ﹤0.01% | 6652 |
|
|
2017
Q3 | $4K | Sell |
300
-7,746
| -96% | -$122K | ﹤0.01% | 6920 |
|
|
2017
Q2 | $149K | Buy |
8,046
+7,639
| +1,877% | +$133K | ﹤0.01% | 5026 |
|
|
2017
Q1 | $7K | Sell |
407
-8,461
| -95% | -$169K | ﹤0.01% | 6712 |
|
|
2016
Q4 | $189K | Buy |
8,868
+8,152
| +1,139% | +$167K | ﹤0.01% | 5328 |
|
|
2016
Q3 | $13K | Sell |
716
-162
| -18% | -$3.65K | ﹤0.01% | 6428 |
|
|
2016
Q2 | $25K | Buy |
+878
| New | +$24.4K | ﹤0.01% | 6033 |
|
Citigroup's ARA Position: Q1 2021 in Review
Citigroup sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 2,755 shares — an estimated $31K sold.
Citigroup first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $189K in Q4 2016. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Citigroup reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Citigroup sold 2,755 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $31K.
- Citigroup first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Citigroup's American Renal Associates Holdings, Inc position peaked at $189K in Q4 2016.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.